Cambridge Investment Research Advisors Inc. reduced its position in shares of Addus Homecare Co. (NASDAQ:ADUS) by 4.9% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,282 shares of the company’s stock after selling 1,004 shares during the quarter. Cambridge Investment Research Advisors Inc. owned 0.16% of Addus Homecare worth $1,104,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Rhumbline Advisers grew its stake in shares of Addus Homecare by 14.5% in the second quarter. Rhumbline Advisers now owns 7,630 shares of the company’s stock worth $437,000 after acquiring an additional 964 shares during the period. OppenheimerFunds Inc. grew its stake in shares of Addus Homecare by 0.6% in the first quarter. OppenheimerFunds Inc. now owns 218,284 shares of the company’s stock worth $10,619,000 after acquiring an additional 1,300 shares during the period. First Trust Advisors LP grew its stake in shares of Addus Homecare by 18.9% in the second quarter. First Trust Advisors LP now owns 8,480 shares of the company’s stock worth $485,000 after acquiring an additional 1,347 shares during the period. Globeflex Capital L P grew its position in Addus Homecare by 5.5% during the second quarter. Globeflex Capital L P now owns 32,700 shares of the company’s stock valued at $1,872,000 after buying an additional 1,700 shares during the period. Finally, Wedge Capital Management L L P NC grew its position in Addus Homecare by 7.5% during the second quarter. Wedge Capital Management L L P NC now owns 27,778 shares of the company’s stock valued at $1,590,000 after buying an additional 1,930 shares during the period. Institutional investors and hedge funds own 82.54% of the company’s stock.
ADUS traded up $1.15 during trading hours on Friday, hitting $65.05. The company’s stock had a trading volume of 89,949 shares, compared to its average volume of 91,021. Addus Homecare Co. has a 12 month low of $30.95 and a 12 month high of $72.55. The stock has a market capitalization of $896.00 million, a PE ratio of 44.86, a P/E/G ratio of 2.81 and a beta of -0.54. The company has a debt-to-equity ratio of 0.53, a quick ratio of 3.09 and a current ratio of 3.09.
Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings results on Tuesday, August 7th. The company reported $0.50 earnings per share for the quarter, missing the consensus estimate of $0.51 by ($0.01). Addus Homecare had a return on equity of 10.45% and a net margin of 3.43%. The business had revenue of $131.24 million during the quarter, compared to the consensus estimate of $127.81 million. As a group, research analysts forecast that Addus Homecare Co. will post 1.67 earnings per share for the current year.
In other Addus Homecare news, major shareholder Eos Capital Partners Iii L. P sold 1,024,733 shares of the business’s stock in a transaction on Monday, August 20th. The shares were sold at an average price of $59.00, for a total transaction of $60,459,247.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 34.80% of the company’s stock.
Several analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of Addus Homecare from a “buy” rating to a “strong sell” rating in a report on Monday, June 11th. BidaskClub downgraded shares of Addus Homecare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 10th. Cantor Fitzgerald assumed coverage on shares of Addus Homecare in a report on Wednesday, September 12th. They issued an “overweight” rating and a $77.00 target price on the stock. Raymond James assumed coverage on shares of Addus Homecare in a report on Monday, August 20th. They issued an “outperform” rating and a $75.00 target price on the stock. Finally, Stephens boosted their target price on shares of Addus Homecare from $67.00 to $75.00 and gave the stock an “overweight” rating in a report on Tuesday, August 7th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $71.29.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Recommended Story: Market Capitalization – What it Means for Investors
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.